Previous 10 | Next 10 |
SEATTLE, March 04, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate and utilize the healthcare system and their workplace benefits, today announced it has completed the acquisition ...
SEATTLE, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, will participate in the following upcoming i...
New Independent Study Finds Accolade Significantly Bends the Healthcare Cost Curve for Employer Aon study shows that Accolade lowered employer claims costs across major clinical categories and risk groups PR Newswire SEATTLE , Feb. 4, 2021 /PRNewswire/ -- Hea...
Accolade Welcomes Cindy R. Kent to its Board of Directors Business leader, healthcare executive and one of Savoy Magazine's 2020 leading executives is driving positive change for the healthcare experience in the U.S. PR Newswire SEATTLE , Jan. 27, 2021 /PRNew...
The following slide deck was published by Accolade, Inc. in conjunction with this event. For further details see: Accolade (ACCD) Announces Acquisition of 2nd MD - Slideshow
The Q4 earnings season cranks up with Procter & Gamble (PG), Netflix (NFLX) and Intel (INTC) some of the more intriguing names to spill numbers. It is week two of trading for Poshmark (POSH) and Petco (WOOF) after huge first day gains were pared a bit on Friday. The economic calendar brin...
Charah Solutions (CHRA) +105% on being awarded large-scale, 12-Year ash marketing contract.DBV Technologies (DBVT) +57% on FDA response regarding Viaskin Peanut application.ObsEva (OBSV) +43%.Atlantic Power (AT) +41% on being acquired by I Squared Capital.Senseonics Holdings (S...
Accolade (ACCD) signed a definitive agreement to acquire Innovation Specialists, LLC (d/b/a 2nd.MD), a leading Expert Medical Opinion and medical decision support company based in Houston, TX.Purchase price of up to $460M will consist of $230M in cash, $130M in Accolade common stock, and up t...
The addition of 2nd.MD’s Expert Medical Opinion services to Accolade’s portfolio of high-touch, technology-enabled health and benefits solutions expands Accolade’s clinical capabilities and creates the market’s most comprehensive, integrated healthcare navigati...
Accolade integrates workplace benefits into one platform and helps organizations save on employee healthcare costs through a virtual concierge service. The company launched its IPO in July of 2020 and is presenting strong growth with a positive operational outlook. We are bullish ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...